Top Markets
#1 Black Phoenix Black Phoenix +166.51%
#2 Islamic Coin Islamic Coin +158.21%
#3 Glidr Glidr +58.56%
#4 Cryptopia Cryptopia +20.42%
#5 DOVU DOVU +19.60%
#6 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.07%
#7 Test Test +11.85%
#8 Wrapped Bitcoin (PulseChain) Wrapped Bitcoin (PulseChain) +11.09%
#9 MarsCoin MarsCoin +10.39%
#10 stake.link stake.link +8.68%
Coin of the day
Black Phoenix Black Phoenix
Settings
Language
ENGLISH
Currency
USD
Theme
Ehouse Global, Inc. Ehouse Global, Inc.

Ehouse Global, Inc.

EHOS
Rank in Stocks #41788
Ehouse Global, Inc. specializes in the formulation, production, and... Ehouse Global, Inc. specializes in the formulation, production, and distribution of liquid nutritional supplements. The company's diverse product portfolio features a variety of liquid offerings, including essential vitamins, minerals, athletic performance enhancers, dietary support solutions, and general well-being products. Co-founded in 2003 by Scott Corlett and Edward J. Peplinski, the firm's corporate headquarters are located in San Diego, California.
Share Price
$0.00001
Last synced: 2026-08-11
Market Cap
$10.13K
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Ehouse Global, Inc. (EHOS)

Category

Healthcare
Revenue for Ehouse Global, Inc. (EHOS)
Revenue in Aug 2026 TTM: 0
According to Ehouse Global, Inc. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Ehouse Global, Inc. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $10.11B -
BE
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR